FDA sends letter to Novo Nordisk over potential GLP-1 side effects
The U.S. Food and Drug Administration sent a warning letter this month to Novo Nordisk, the maker of…
FDA sends letter to Novo Nordisk over potential GLP-1 side effects
The U.S. Food and Drug Administration sent a warning letter this month to Novo Nordisk, the maker of…
Commerce Commission investigates creatine supplement maker Push Gummies after 34 complaints
Brittany Allan, co-founder of Push Gummies, said the business was planning to relaunch in the coming weeks. In…
UK pub market faces structural shift as managed operators gain ground
This is despite these operators only comprising of just over a quarter of sites, the Lumina Intelligence Pub…